Botensilimab (Fc-enhanced anti-cytotoxic lymphocyte-association protein-4 antibody) Plus Balstilimab (anti-PD-1 antibody) in Patients With Relapsed/Refractory Metastatic Sarcomas.

Saved in:
Bibliographic Details
Title: Botensilimab (Fc-enhanced anti-cytotoxic lymphocyte-association protein-4 antibody) Plus Balstilimab (anti-PD-1 antibody) in Patients With Relapsed/Refractory Metastatic Sarcomas.
Authors: Wilky BA; University of Colorado Cancer Center, Aurora, CO., Schwartz GK; Case Comprehensive Cancer Center, Cleveland, OH., Gordon MS; HonorHealth Research Institute, Scottsdale, AZ., El-Khoueiry AB; University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA., Bullock AJ; Beth Israel Deaconess Medical Center, Boston, MA., Henick B; Herbert Irving Comprehensive Cancer Center at Columbia University School of Medicine, New York, NY., Agulnik M; University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA., Singh A; University of California Los Angeles, Los Angeles, CA., Mahadevan D; The University of Texas Health Sciences Center at San Antonio, San Antonio, TX., Stebbing J; Anglia Ruskin University, School of Life Sciences, Cambridge, United Kingdom., Delepine C; Agenus Inc, Lexington, MA., Chand D; Agenus Inc, Lexington, MA., Avagyan M; Agenus Inc, Lexington, MA., Wu W; Agenus Inc, Lexington, MA., Johnson B; Agenus Inc, Lexington, MA., Grossman JE; Agenus Inc, Lexington, MA., O'Day S; Agenus Inc, Lexington, MA., Trent JC; Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL., Jones RL; The Royal Marsden Hospital and Institute of Cancer Research, London, United Kingdom., Tsimberidou AM; The University of Texas MD Anderson Cancer Center, Houston, TX.
Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2025 Apr 10; Vol. 43 (11), pp. 1358-1368. Date of Electronic Publication: 2025 Jan 27.
Publication Type: Journal Article; Clinical Trial, Phase I; Multicenter Study; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39869830
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Botensilimab (Fc-enhanced anti-cytotoxic lymphocyte-association protein-4 antibody) Plus Balstilimab (anti-PD-1 antibody) in Patients With Relapsed/Refractory Metastatic Sarcomas.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Wilky+BA%22">Wilky BA</searchLink>; University of Colorado Cancer Center, Aurora, CO.<br /><searchLink fieldCode="AU" term="%22Schwartz+GK%22">Schwartz GK</searchLink>; Case Comprehensive Cancer Center, Cleveland, OH.<br /><searchLink fieldCode="AU" term="%22Gordon+MS%22">Gordon MS</searchLink>; HonorHealth Research Institute, Scottsdale, AZ.<br /><searchLink fieldCode="AU" term="%22El-Khoueiry+AB%22">El-Khoueiry AB</searchLink>; University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA.<br /><searchLink fieldCode="AU" term="%22Bullock+AJ%22">Bullock AJ</searchLink>; Beth Israel Deaconess Medical Center, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Henick+B%22">Henick B</searchLink>; Herbert Irving Comprehensive Cancer Center at Columbia University School of Medicine, New York, NY.<br /><searchLink fieldCode="AU" term="%22Agulnik+M%22">Agulnik M</searchLink>; University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA.<br /><searchLink fieldCode="AU" term="%22Singh+A%22">Singh A</searchLink>; University of California Los Angeles, Los Angeles, CA.<br /><searchLink fieldCode="AU" term="%22Mahadevan+D%22">Mahadevan D</searchLink>; The University of Texas Health Sciences Center at San Antonio, San Antonio, TX.<br /><searchLink fieldCode="AU" term="%22Stebbing+J%22">Stebbing J</searchLink>; Anglia Ruskin University, School of Life Sciences, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Delepine+C%22">Delepine C</searchLink>; Agenus Inc, Lexington, MA.<br /><searchLink fieldCode="AU" term="%22Chand+D%22">Chand D</searchLink>; Agenus Inc, Lexington, MA.<br /><searchLink fieldCode="AU" term="%22Avagyan+M%22">Avagyan M</searchLink>; Agenus Inc, Lexington, MA.<br /><searchLink fieldCode="AU" term="%22Wu+W%22">Wu W</searchLink>; Agenus Inc, Lexington, MA.<br /><searchLink fieldCode="AU" term="%22Johnson+B%22">Johnson B</searchLink>; Agenus Inc, Lexington, MA.<br /><searchLink fieldCode="AU" term="%22Grossman+JE%22">Grossman JE</searchLink>; Agenus Inc, Lexington, MA.<br /><searchLink fieldCode="AU" term="%22O'Day+S%22">O'Day S</searchLink>; Agenus Inc, Lexington, MA.<br /><searchLink fieldCode="AU" term="%22Trent+JC%22">Trent JC</searchLink>; Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL.<br /><searchLink fieldCode="AU" term="%22Jones+RL%22">Jones RL</searchLink>; The Royal Marsden Hospital and Institute of Cancer Research, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Tsimberidou+AM%22">Tsimberidou AM</searchLink>; The University of Texas MD Anderson Cancer Center, Houston, TX.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228309333%22">Journal of clinical oncology : official journal of the American Society of Clinical Oncology</searchLink> [J Clin Oncol] 2025 Apr 10; Vol. 43 (11), pp. 1358-1368. <i>Date of Electronic Publication: </i>2025 Jan 27.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase I; Multicenter Study; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Clinical+Oncology%22">American Society of Clinical Oncology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8309333 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1527-7755 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220732183X%22">0732183X </searchLink><i>NLM ISO Abbreviation: </i>J Clin Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39869830
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1200/JCO-24-02524
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1358
    Titles:
      – TitleFull: Botensilimab (Fc-enhanced anti-cytotoxic lymphocyte-association protein-4 antibody) Plus Balstilimab (anti-PD-1 antibody) in Patients With Relapsed/Refractory Metastatic Sarcomas.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Wilky BA
      – PersonEntity:
          Name:
            NameFull: Schwartz GK
      – PersonEntity:
          Name:
            NameFull: Gordon MS
      – PersonEntity:
          Name:
            NameFull: El-Khoueiry AB
      – PersonEntity:
          Name:
            NameFull: Bullock AJ
      – PersonEntity:
          Name:
            NameFull: Henick B
      – PersonEntity:
          Name:
            NameFull: Agulnik M
      – PersonEntity:
          Name:
            NameFull: Singh A
      – PersonEntity:
          Name:
            NameFull: Mahadevan D
      – PersonEntity:
          Name:
            NameFull: Stebbing J
      – PersonEntity:
          Name:
            NameFull: Delepine C
      – PersonEntity:
          Name:
            NameFull: Chand D
      – PersonEntity:
          Name:
            NameFull: Avagyan M
      – PersonEntity:
          Name:
            NameFull: Wu W
      – PersonEntity:
          Name:
            NameFull: Johnson B
      – PersonEntity:
          Name:
            NameFull: Grossman JE
      – PersonEntity:
          Name:
            NameFull: O'Day S
      – PersonEntity:
          Name:
            NameFull: Trent JC
      – PersonEntity:
          Name:
            NameFull: Jones RL
      – PersonEntity:
          Name:
            NameFull: Tsimberidou AM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 10
              M: 04
              Text: 2025 Apr 10
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1527-7755
          Numbering:
            – Type: volume
              Value: 43
            – Type: issue
              Value: 11
          Titles:
            – TitleFull: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
              Type: main
ResultId 1